Primary Care Practices for Coronavirus

Oklahoma Clinical and Translational Science Institute, Oklahoma City, OK
Dissemination and Implementation ResearchN/AWaitlist AvailableLed by Judith A James, MD, PhDResearch Sponsored by University of Oklahoma

Study Summary

This trial will help Oklahoma primary care practices implement guidelines-based testing and patient education about COVID-19, and deploy mobile testing sites to increase the efficiency of state-wide testing by Oklahoma's public health authorities.

Eligible Conditions
  • Coronavirus


Screening ~ 3 weeks
Treatment ~ Varies
Follow ups ~ month 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Barriers to SARS-CoV-2 Testing (Practices)
Change in SARS-CoV-2 Test Positivity Rate (Community Sites)
Change in SARS-CoV-2 Testing Rate (Practices)
Secondary outcome measures
COVID-19 Referrals
Change in Influenza Vaccination Rate (NQF #41)
Change in Pneumococcal Vaccination Rate (NQF #127)
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Primary Care PracticesExperimental Treatment1 Intervention
A practice-based implementation study will be conducted with 50 practices, with baseline data collection, and overlapping with interim measurements of care quality and process outcomes, followed by a final data collection at the end of the intervention (including baseline measures plus semi-structured interviews. The practice based approach to increasing testing will be compared to a community-based approach using mobile-setting to increase testing. Additional, non-clinical trial components of this study include patient surveys to understand facilitators and barriers to SARS-CoV-2 testing and identification of legal/ethical, socioeconomic, and behavioral implications of increased testing. Patients are not direct subjects in this part of the study. Intervention will target practices and practice members.

Find a site

Who is running the clinical trial?

University of OklahomaLead Sponsor
440 Previous Clinical Trials
98,814 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,595 Previous Clinical Trials
6,794,474 Total Patients Enrolled
National Institute of General Medical Sciences (NIGMS)NIH
242 Previous Clinical Trials
94,048 Total Patients Enrolled
Judith A James, MD, PhDPrincipal Investigator
University of Oklahoma
1 Previous Clinical Trials
2,000 Total Patients Enrolled

Media Library

Primary Care Practices Clinical Trial Eligibility Overview. Trial Name: NCT04870307 — N/A
Coronavirus Research Study Groups: Primary Care Practices
Coronavirus Clinical Trial 2023: Primary Care Practices Highlights & Side Effects. Trial Name: NCT04870307 — N/A
Primary Care Practices 2023 Treatment Timeline for Medical Study. Trial Name: NCT04870307 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the central goals of this scientific experiment?

"This medical trial will evaluate the SARS-CoV-2 Test Positivity Rate in multiple communities over a 12 month period. Additionally, it seeks to measure changes in Zoster Vaccination Rates among those aged 50 and older, alterations of the Pneumococcal Vaccination Rates for seniors 65 or above, as well as track COVID-19 Referrals generated by this study."

Answered by AI

Are there any remaining opportunities to partake in this research endeavor?

"From the data hosted on, it appears that this particular medical trial is not currently recruiting patients. The study was initially posted to the website in September of 2020 and last updated on May 25th 2022; however, there are 1040 other trials actively looking for participants at this time."

Answered by AI

Who else is applying?

What state do they live in?
How old are they?
18 - 65
What site did they apply to?
Oklahoma Clinical and Translational Science Institute
What portion of applicants met pre-screening criteria?
Met criteria
~199 spots leftby Sep 2024